| # | Title | Journal | Year | Citations |
|---|
| 1 | Plasma Hsp90 levels in patients with systemic sclerosis and relation to lung and skin involvement: a cross-sectional and longitudinal study | Scientific Reports | 2021 | 9,439 |
| 2 | 2016 updated EULAR evidence-based recommendations for the management of gout | Annals of the Rheumatic Diseases | 2017 | 1,096 |
| 3 | 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups | Annals of the Rheumatic Diseases | 2017 | 754 |
| 4 | Current vitamin D status in European and Middle East countries and strategies to prevent vitamin D deficiency: a position statement of the European Calcified Tissue Society | European Journal of Endocrinology | 2019 | 443 |
| 5 | Mapping and predicting mortality from systemic sclerosis | Annals of the Rheumatic Diseases | 2017 | 410 |
| 6 | Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis | Annals of the Rheumatic Diseases | 2011 | 345 |
| 7 | A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis | Osteoporosis International | 2012 | 291 |
| 8 | Resistin in rheumatoid arthritis synovial tissue, synovial fluid and serum | Annals of the Rheumatic Diseases | 2006 | 226 |
| 9 | Idiopathic inflammatory myopathies | Nature Reviews Disease Primers | 2021 | 212 |
| 10 | EULAR definition of arthralgia suspicious for progression to rheumatoid arthritis | Annals of the Rheumatic Diseases | 2017 | 209 |
| 11 | Association of circulating miR-223 and miR-16 with disease activity in patients with early rheumatoid arthritis | Annals of the Rheumatic Diseases | 2014 | 165 |
| 12 | The role of pain and functional impairment in the decision to recommend total joint replacement in hip and knee osteoarthritis: an international cross-sectional study of 1909 patients. Report of the OARSI-OMERACT Task Force on total joint replacement | Osteoarthritis and Cartilage | 2011 | 162 |
| 13 | Health-related quality of life and radiographic vertebral fracture | Osteoporosis International | 2004 | 161 |
| 14 | Low bone mineral density is associated with bone microdamage accumulation in postmenopausal women with osteoporosis | Bone | 2007 | 141 |
| 15 | Teriparatide for osteoporosis: importance of the full course | Osteoporosis International | 2016 | 135 |
| 16 | A randomised phase IIb study of mavrilimumab, a novel GM–CSF receptor alpha monoclonal antibody, in the treatment of rheumatoid arthritis | Annals of the Rheumatic Diseases | 2017 | 117 |
| 17 | Disease specificity of autoantibodies to cytosolic 5′-nucleotidase 1A in sporadic inclusion body myositis versus known autoimmune diseases | Annals of the Rheumatic Diseases | 2016 | 116 |
| 18 | Genome-wide association study identifies HLA 8.1 ancestral haplotype alleles as major genetic risk factors for myositis phenotypes | Genes and Immunity | 2015 | 103 |
| 19 | EQ-5D in Central and Eastern Europe: 2000–2015 | Quality of Life Research | 2016 | 103 |
| 20 | Interaction of HLA-DRB1*03 and smoking for the development of anti-Jo-1 antibodies in adult idiopathic inflammatory myopathies: a European-wide case study | Annals of the Rheumatic Diseases | 2012 | 100 |
| 21 | Use of Intraarticular Hyaluronic Acid in the Management of Knee Osteoarthritis in Clinical Practice | Arthritis Care and Research | 2017 | 95 |
| 22 | Heat shock protein 90 (Hsp90) inhibition targets canonical TGF-β signalling to prevent fibrosis | Annals of the Rheumatic Diseases | 2014 | 78 |
| 23 | Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative project | Annals of the Rheumatic Diseases | 2017 | 77 |
| 24 | A Randomized Phase IIb Study of Mavrilimumab and Golimumab in Rheumatoid Arthritis | Arthritis and Rheumatology | 2018 | 76 |
| 25 | Pharmaceutical-grade Chondroitin sulfate is as effective as celecoxib and superior to placebo in symptomatic knee osteoarthritis: the ChONdroitin versus CElecoxib versus Placebo Trial (CONCEPT) | Annals of the Rheumatic Diseases | 2017 | 75 |
| 26 | Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): randomised, double-blind, placebo-controlled multicentre trial | Annals of the Rheumatic Diseases | 2020 | 71 |
| 27 | Teriparatide Reduces Bone Microdamage Accumulation in Postmenopausal Women Previously Treated With Alendronate | Journal of Bone and Mineral Research | 2009 | 69 |
| 28 | Decreases in serum levels of S100A8/9 (calprotectin) correlate with improvements in total swollen joint count in patients with recent-onset rheumatoid arthritis | Arthritis Research and Therapy | 2011 | 69 |
| 29 | Effects of teriparatide on cortical histomorphometric variables in postmenopausal women with or without prior alendronate treatment | Bone | 2014 | 69 |
| 30 | A synthetic PPAR-γ agonist triterpenoid ameliorates experimental fibrosis: PPAR-γ-independent suppression of fibrotic responses | Annals of the Rheumatic Diseases | 2014 | 62 |
| 31 | Effect of 1 year cyclosporine a treatment on the activity and renal involvement of systemic lupus erythematosus: a pilot study | Lupus | 1998 | 59 |
| 32 | Increasing the infliximab dose in rheumatoid arthritis patients: a randomised, double blind study failed to confirm its efficacy | Annals of the Rheumatic Diseases | 2009 | 59 |
| 33 | Efficacy and safety of piascledine 300 versus chondroitin sulfate in a 6 months treatment plus 2 months observation in patients with osteoarthritis of the knee | Clinical Rheumatology | 2010 | 59 |
| 34 | Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration | Annals of the Rheumatic Diseases | 2019 | 58 |
| 35 | The metastasis associated protein S100A4: a potential novel link to inflammation and consequent aggressive behaviour of rheumatoid arthritis synovial fibroblasts | Annals of the Rheumatic Diseases | 2008 | 57 |
| 36 | Incidence and prevalence of psoriatic arthritis, ankylosing spondylitis, and reactive arthritis in the first descriptive population-based study in the Czech Republic | Scandinavian Journal of Rheumatology | 2010 | 57 |
| 37 | Epidemiology of rheumatoid arthritis, juvenile idiopathic arthritis and gout in two regions of the Czech Republic in a descriptive population-based survey in 2002-2003 | Clinical and Experimental Rheumatology | 2006 | 56 |
| 38 | Histomorphometric changes by teriparatide in alendronate-pretreated women with osteoporosis | Osteoporosis International | 2010 | 55 |
| 39 | Low circulating Dickkopf-1 and its link with severity of spinal involvement in diffuse idiopathic skeletal hyperostosis | Annals of the Rheumatic Diseases | 2012 | 55 |
| 40 | Increasing incidence of immune-mediated necrotizing myopathy: single-centre experience | Rheumatology | 2015 | 55 |
| 41 | The transcription factor GLI2 as a downstream mediator of transforming growth factor-β-induced fibroblast activation in SSc | Annals of the Rheumatic Diseases | 2017 | 53 |
| 42 | S100A4 amplifies TGF-β-induced fibroblast activation in systemic sclerosis | Annals of the Rheumatic Diseases | 2015 | 52 |
| 43 | Splicing variant of WDFY4 augments MDA5 signalling and the risk of clinically amyopathic dermatomyositis | Annals of the Rheumatic Diseases | 2018 | 51 |
| 44 | Low-dose estrogen combined oral contraceptives may negatively influence physiological bone mineral density acquisition during adolescence | European Journal of Endocrinology | 2012 | 49 |
| 45 | Vitamin D and calcium supplementation for three years in postmenopausal osteoporosis significantly alters bone mineral and organic matrix quality | Bone | 2017 | 47 |
| 46 | 2017 EULAR recommendations for a core data set to support observational research and clinical care in rheumatoid arthritis | Annals of the Rheumatic Diseases | 2018 | 47 |
| 47 | Anti-TNF therapy of ankylosing spondylitis in clinical practice. Results from the Czech national registry ATTRA | Clinical and Experimental Rheumatology | 2009 | 47 |
| 48 | Pro-inflammatory effects of interleukin-35 in rheumatoid arthritis | Cytokine | 2015 | 44 |
| 49 | URAT1 and GLUT9 mutations in Spanish patients with renal hypouricemia | Clinica Chimica Acta | 2018 | 42 |
| 50 | Prevalence of URAT1 allelic variants in the Roma population | Nucleosides, Nucleotides and Nucleic Acids | 2016 | 41 |
